David Gryska, EVP, CFO at Incyte, holds 10.23K shares in Incyte (Ticker: INCY), holds ― shares in GW Pharma (Ticker: GWPH), holds 17.35K shares in Mind Medicine (Ticker: MNMD).
David Gryska latest transaction was an Uninformative Sell of $31.94K.
What was David Gryska's most profitable transaction?
David Gryska’s most profitable transaction was an Informative Buy of MNMD stock on August 26, 2024. The return on the trade was 38.70%.
What is David Gryska's role in Incyte?
David Gryska's role in Incyte is EVP, CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.